Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02169037
115:137:treatment
willingness, ability and commitment to participate in baseline and follow-up evaluations without participation in another clinical trial (unless documented approval received from both sponsors)
1
[ "willingness", ",", "ability", "and", "commitment", "to", "participate", "in", "baseline", "and", "follow-up", "evaluations", "without", "participation", "in", "another", "clinical", "trial", "(", "unless", "documented", "approval", "received", "from", "both", "sponsors", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02476409
54:90:chronic_disease,203:216:chronic_disease,252:267:chronic_disease
Patients with the following predisposing factors for osmotic demyelinating syndrome (ODS), assessed by the study investigator judgment, will be excluded: chronic alcoholism at the time of study, severe liver disease, marked malnutrition, and risk for chronic hypoxia
1
[ "Patients", "with", "the", "following", "predisposing", "factors", "for", "osmotic", "demyelinating", "syndrome", "(", "ODS", ")", ",", "assessed", "by", "the", "study", "investigator", "judgment", ",", "will", "be", "excluded", ":", "chronic", "alcoholism", "at", "the", "time", "of", "study", ",", "severe", "liver", "disease", ",", "marked", "malnutrition", ",", "and", "risk", "for", "chronic", "hypoxia" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03001830
1:11:cancer
malignancy
1
[ "malignancy" ]
[ 3 ]
NCT02335242
29:66:treatment,76:88:treatment,90:102:treatment,104:116:treatment,118:128:treatment,153:162:treatment
Requires concomitant use of potent cytochrome P450 3A4 inhibitors (such as ketoconazole, itraconazole, erythromycin, saquinavir), or concomitant use of ritonavir
1
[ "Requires", "concomitant", "use", "of", "potent", "cytochrome", "P450", "3A4", "inhibitors", "(", "such", "as", "ketoconazole", ",", "itraconazole", ",", "erythromycin", ",", "saquinavir", ")", ",", "or", "concomitant", "use", "of", "ritonavir" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 1 ]
NCT00703105
37:64:treatment,68:81:treatment,,111:116:cancer
Patients must not have received any antineoplastic chemotherapy or immunotherapy for the four weeks preceding tumor excision
1
[ "Patients", "must", "not", "have", "received", "any", "antineoplastic", "chemotherapy", "or", "immunotherapy", "for", "the", "four", "weeks", "preceding", "tumor", "excision" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 3, 0 ]
NCT02799095
59:70:cancer
the subject has histological or cytological evidence of a solid tumor
1
[ "the", "subject", "has", "histological", "or", "cytological", "evidence", "of", "a", "solid", "tumor" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3 ]
NCT02124772
1:31:treatment
prior treatment with sorafenib
1
[ "prior", "treatment", "with", "sorafenib" ]
[ 1, 1, 1, 1 ]
NCT01811368
18:51:treatment
Patients fit for non-myeloablative transplantation or best treatment that have an available matched (9/10 or better) related or unrelated donor
1
[ "Patients", "fit", "for", "non-myeloablative", "transplantation", "or", "best", "treatment", "that", "have", "an", "available", "matched", "(", "9/10", "or", "better", ")", "related", "or", "unrelated", "donor" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01994382
21:40:cancer
Prior treatment for lymphoid malignancy for progressive /refractory disease
1
[ "Prior", "treatment", "for", "lymphoid", "malignancy", "for", "progressive", "/refractory", "disease" ]
[ 0, 0, 0, 3, 3, 0, 0, 0, 0 ]
NCT02503722
4:13:treatment,39:47:treatment,49:56:treatment,61:82:treatment,88:103:treatment
be treatment naive for 3rd generation EGFR-TKI (CO-1686 and osimertinib [AZD9291]) and mTOR inhibitors
1
[ "be", "treatment", "naive", "for", "3rd", "generation", "EGFR-TKI", "(", "CO-1686", "and", "osimertinib", "[", "AZD9291", "]", ")", "and", "mTOR", "inhibitors" ]
[ 0, 1, 0, 0, 0, 0, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0, 1, 1 ]
NCT02912572
33:45:treatment
patients who have only received chemotherapy in the adjuvant setting
1
[ "patients", "who", "have", "only", "received", "chemotherapy", "in", "the", "adjuvant", "setting" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT01389024
51:59:treatment
The parents or guardians must provide consent for sedation
1
[ "The", "parents", "or", "guardians", "must", "provide", "consent", "for", "sedation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02341235
1:8:treatment,
Surgery in the past six months
1
[ "Surgery", "in", "the", "past", "six", "months" ]
[ 1, 0, 0, 0, 0, 0 ]
NCT01980823
10:22:treatment,24:41:treatment,46:62:treatment,
No prior chemotherapy, radiation therapy, or breast resection within 6 months of study entry
1
[ "No", "prior", "chemotherapy", ",", "radiation", "therapy", ",", "or", "breast", "resection", "within", "6", "months", "of", "study", "entry" ]
[ 0, 0, 1, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02025543
21:47:treatment
contraindication to magnetic resonance imaging
1
[ "contraindication", "to", "magnetic", "resonance", "imaging" ]
[ 0, 0, 1, 1, 1 ]
NCT02152254
26:38:treatment,40:47:treatment,52:64:treatment,,127:136:treatment,150:161:treatment,165:186:treatment
The patient has received chemotherapy, surgery, or radiotherapy (for therapeutic purposes) within 3 weeks of initiating study treatment (4 weeks for bevacizumab or investigational drugs)
1
[ "The", "patient", "has", "received", "chemotherapy", ",", "surgery", ",", "or", "radiotherapy", "(", "for", "therapeutic", "purposes", ")", "within", "3", "weeks", "of", "initiating", "study", "treatment", "(", "4", "weeks", "for", "bevacizumab", "or", "investigational", "drugs", ")" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 1, 1, 0 ]
NCT02446093
1:13:treatment
valacyclovir
1
[ "valacyclovir" ]
[ 1 ]
NCT02646930
63:74:treatment,83:94:treatment,99:135:treatment,139:154:treatment,200:218:treatment,
Post-enrollment exclusion will include patients receiving any antibiotics, except prophylaxis for transvaginal oocyte retrieval (TVOR) or glucocorticoids, except nasal preparations, from the time of endometrial biopsy until initial transvaginal ultrasound (TVUS) for pregnancy
1
[ "Post-enrollment", "exclusion", "will", "include", "patients", "receiving", "any", "antibiotics", ",", "except", "prophylaxis", "for", "transvaginal", "oocyte", "retrieval", "(", "TVOR", ")", "or", "glucocorticoids", ",", "except", "nasal", "preparations", ",", "from", "the", "time", "of", "endometrial", "biopsy", "until", "initial", "transvaginal", "ultrasound", "(", "TVUS", ")", "for", "pregnancy" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 1, 1, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02226341
38:43:chronic_disease,45:52:chronic_disease,54:67:chronic_disease,69:85:chronic_disease,87:96:chronic_disease,98:105:chronic_disease,110:130:chronic_disease,338:341:chronic_disease
Severe, progressive, or uncontrolled renal, hepatic, hematological, gastrointestinal, pulmonary, cardiac, or neurological disease (or, in the investigator's opinion, any other concomitant medical condition that places the participant at risk by participating in this study) with the exception of diseases or conditions related to active SLE
1
[ "Severe", ",", "progressive", ",", "or", "uncontrolled", "renal", ",", "hepatic", ",", "hematological", ",", "gastrointestinal", ",", "pulmonary", ",", "cardiac", ",", "or", "neurological", "disease", "(", "or", ",", "in", "the", "investigator", "'s", "opinion", ",", "any", "other", "concomitant", "medical", "condition", "that", "places", "the", "participant", "at", "risk", "by", "participating", "in", "this", "study", ")", "with", "the", "exception", "of", "diseases", "or", "conditions", "related", "to", "active", "SLE" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT01726257
32:54:treatment
Participating in enrollment of another clinical study
1
[ "Participating", "in", "enrollment", "of", "another", "clinical", "study" ]
[ 0, 0, 0, 0, 1, 1, 1 ]
NCT02442323
1:19:cancer
mucinous carcinoma
1
[ "mucinous", "carcinoma" ]
[ 3, 3 ]
NCT01928576
,57:69:treatment,,102:111:treatment,116:137:cancer
Patients must have received at least one platinum based chemotherapy, and not more than three, prior therapies for stage IIIB/IV disease
1
[ "Patients", "must", "have", "received", "at", "least", "one", "platinum", "based", "chemotherapy", ",", "and", "not", "more", "than", "three", ",", "prior", "therapies", "for", "stage", "IIIB/IV", "disease" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 3, 3, 3 ]
NCT02607514
1:19:chronic_disease,62:79:chronic_disease,81:103:chronic_disease,105:117:chronic_disease,,,,156:167:chronic_disease,,223:246:chronic_disease,328:348:chronic_disease,350:360:cancer,365:386:chronic_disease
Medical conditions that may make participation unsafe (e.g., diabetes [I & II], cardiovascular disease, hypertension [>140 systolic and/or >90 diastolic], hypotension [<90 systolic and/or <60 diastolic, during screening], orthostatic hypotension [systolic drop of 20 points or 10 point diastolic or heart rate increase by 10], autoimmune disorders, malignancy, or autonomic dysfunction)
1
[ "Medical", "conditions", "that", "may", "make", "participation", "unsafe", "(", "e.g.", ",", "diabetes", "[", "I", "&", "II", "]", ",", "cardiovascular", "disease", ",", "hypertension", "[", ">", "140", "systolic", "and/or", ">", "90", "diastolic", "]", ",", "hypotension", "[", "<", "90", "systolic", "and/or", "<", "60", "diastolic", ",", "during", "screening", "]", ",", "orthostatic", "hypotension", "[", "systolic", "drop", "of", "20", "points", "or", "10", "point", "diastolic", "or", "heart", "rate", "increase", "by", "10", "]", ",", "autoimmune", "disorders", ",", "malignancy", ",", "or", "autonomic", "dysfunction", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 3, 0, 0, 2, 2, 0 ]
NCT02475707
44:102:treatment
Only patients who receive infusions in the integrated Cell and Gene Therapy (CAGT) Transplant program at Texas Children's Hospital (TCH) or Houston Methodist Hospital (HMH)
1
[ "Only", "patients", "who", "receive", "infusions", "in", "the", "integrated", "Cell", "and", "Gene", "Therapy", "(", "CAGT", ")", "Transplant", "program", "at", "Texas", "Children", "'s", "Hospital", "(", "TCH", ")", "or", "Houston", "Methodist", "Hospital", "(", "HMH", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03028350
5:32:treatment,62:74:treatment,76:88:treatment,90:103:treatment,105:115:treatment,117:121:treatment,123:136:treatment,138:151:treatment,153:171:treatment,173:185:treatment,191:207:treatment,
Any immunosuppressive treatment including but not limited to methotrexate, cyclosporine, mycophenolate, tacrolimus, gold, penicillamine, sulfasalazine, hydroxychloroquine, azathioprine, and cyclophosphamide in the last two weeks before starting treatment
1
[ "Any", "immunosuppressive", "treatment", "including", "but", "not", "limited", "to", "methotrexate", ",", "cyclosporine", ",", "mycophenolate", ",", "tacrolimus", ",", "gold", ",", "penicillamine", ",", "sulfasalazine", ",", "hydroxychloroquine", ",", "azathioprine", ",", "and", "cyclophosphamide", "in", "the", "last", "two", "weeks", "before", "starting", "treatment" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02920710
17:46:treatment
Stable baseline immunosuppressive medications
1
[ "Stable", "baseline", "immunosuppressive", "medications" ]
[ 0, 0, 1, 1 ]
NCT02563574
13:21:chronic_disease
Evidence of dementia
1
[ "Evidence", "of", "dementia" ]
[ 0, 0, 2 ]
NCT02353819
16:26:cancer,
Prior invasive malignancy unless disease free for a minimum of 3 years
1
[ "Prior", "invasive", "malignancy", "unless", "disease", "free", "for", "a", "minimum", "of", "3", "years" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02320292
19:31:treatment
No indication for chemotherapy
1
[ "No", "indication", "for", "chemotherapy" ]
[ 0, 0, 0, 1 ]
NCT02048371
5:15:chronic_disease,,,
Any hemorrhage or bleeding event ≥ NCI CTCAE Grade 3 within 4 weeks prior to study registration
1
[ "Any", "hemorrhage", "or", "bleeding", "event", "≥", "NCI", "CTCAE", "Grade", "3", "within", "4", "weeks", "prior", "to", "study", "registration" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02061761
20:31:treatment,33:36:cancer,38:40:cancer,42:45:cancer
For dose expansion monotherapy: CLL, HL, NHL
1
[ "For", "dose", "expansion", "monotherapy", ":", "CLL", ",", "HL", ",", "NHL" ]
[ 0, 0, 0, 1, 0, 3, 0, 3, 0, 3 ]
NCT01243931
6:23:chronic_disease
Deep corneal opacities and irregularities
1
[ "Deep", "corneal", "opacities", "and", "irregularities" ]
[ 0, 2, 2, 0, 0 ]
NCT01983462
4:21:treatment,29:36:treatment,38:46:treatment,49:56:treatment,58:69:treatment,72:79:treatment,81:101:treatment,115:143:treatment,
On weight loss drugs (e.g., Xenical (orlistat), Meridia (sibutramine), Acutrim (phenylpropanol-amine), or similar over-the-counter medications) within 3 months of screening
1
[ "On", "weight", "loss", "drugs", "(", "e.g.", ",", "Xenical", "(", "orlistat", ")", ",", "Meridia", "(", "sibutramine", ")", ",", "Acutrim", "(", "phenylpropanol-amine", ")", ",", "or", "similar", "over-the-counter", "medications", ")", "within", "3", "months", "of", "screening" ]
[ 0, 1, 1, 1, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT02344355
7:10:chronic_disease
Known HIV-positive individuals
1
[ "Known", "HIV-positive", "individuals" ]
[ 0, 2, 0 ]
NCT01737502
1:20:chronic_disease
labile hypertension
1
[ "labile", "hypertension" ]
[ 2, 2 ]
NCT02128100
1:4:chronic_disease
HIV testing is not manditory for this protocol
1
[ "HIV", "testing", "is", "not", "manditory", "for", "this", "protocol" ]
[ 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02437851
7:16:treatment,24:33:chronic_disease,45:73:chronic_disease,78:109:chronic_disease,
Acute treatment for an infection (excluding fungal infection of the skin and sexually transmitted infections) or other serious medical illness within 2 weeks before enrollment
1
[ "Acute", "treatment", "for", "an", "infection", "(", "excluding", "fungal", "infection", "of", "the", "skin", "and", "sexually", "transmitted", "infections", ")", "or", "other", "serious", "medical", "illness", "within", "2", "weeks", "before", "enrollment" ]
[ 0, 1, 0, 0, 2, 0, 0, 2, 2, 2, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02383979
50:54:treatment
Cooperative, with time and availability to do an fMRI
1
[ "Cooperative", ",", "with", "time", "and", "availability", "to", "do", "an", "fMRI" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02518594
18:46:treatment,
Participation in another interventional study that influences gestational age at delivery or neonatal morbidity or mortality
1
[ "Participation", "in", "another", "interventional", "study", "that", "influences", "gestational", "age", "at", "delivery", "or", "neonatal", "morbidity", "or", "mortality" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00788164
15:19:allergy_name
No allergy to eggs
1
[ "No", "allergy", "to", "eggs" ]
[ 0, 0, 0, 4 ]
NCT03112824
1:25:treatment
anti-insomnia medication on a regular basis
1
[ "anti-insomnia", "medication", "on", "a", "regular", "basis" ]
[ 1, 1, 0, 0, 0, 0 ]
NCT02567422
1:10:cancer
Carcinoma of the neck of unknown primary site origin (regardless of HPV/p16 status)
1
[ "Carcinoma", "of", "the", "neck", "of", "unknown", "primary", "site", "origin", "(", "regardless", "of", "HPV/p16", "status", ")" ]
[ 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02981069
30:64:chronic_disease,,,,,,,
Individuals with evidence of proliferative diabetic retinopathy, plasma creatinine >1.4 females or >1.5 males, or 24-hour urine albumin excretion > 300 mg will be excluded
1
[ "Individuals", "with", "evidence", "of", "proliferative", "diabetic", "retinopathy", ",", "plasma", "creatinine", ">", "1.4", "females", "or", ">", "1.5", "males", ",", "or", "24-hour", "urine", "albumin", "excretion", ">", "300", "mg", "will", "be", "excluded" ]
[ 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02393885
23:66:treatment,79:91:chronic_disease,93:113:chronic_disease,118:127:chronic_disease
Documented history of previous catheter ablation with perforation, history of pericarditis, pericardial effusion, or tamponade
1
[ "Documented", "history", "of", "previous", "catheter", "ablation", "with", "perforation", ",", "history", "of", "pericarditis", ",", "pericardial", "effusion", ",", "or", "tamponade" ]
[ 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 2, 0, 2, 2, 0, 0, 2 ]
NCT02189889
1:7:chronic_disease,11:21:chronic_disease,42:55:treatment
sepsis or bacteremia defined by positive blood culture
1
[ "sepsis", "or", "bacteremia", "defined", "by", "positive", "blood", "culture" ]
[ 2, 0, 2, 0, 0, 0, 1, 1 ]
NCT01893554
14:25:treatment,41:62:treatment,67:80:chronic_disease,,117:128:treatment,165:184:treatment
Has received antibiotics or systemic or nasal steroid therapy for acute illness within the previous 3 days prior to vaccination (steroid skin creams or lotions and topical antibiotics or antifungal preparations are permitted)
1
[ "Has", "received", "antibiotics", "or", "systemic", "or", "nasal", "steroid", "therapy", "for", "acute", "illness", "within", "the", "previous", "3", "days", "prior", "to", "vaccination", "(", "steroid", "skin", "creams", "or", "lotions", "and", "topical", "antibiotics", "or", "antifungal", "preparations", "are", "permitted", ")" ]
[ 0, 0, 1, 0, 0, 0, 1, 1, 1, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT00358657
14:48:chronic_disease
Positive for human immunodeficiency virus (HIV)
1
[ "Positive", "for", "human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02562235
1:13:treatment,,
Pretreatment with NO donors (e.g. nitrates) within the last 2-weeks before visit 1
1
[ "Pretreatment", "with", "NO", "donors", "(", "e.g", ".", "nitrates", ")", "within", "the", "last", "2-weeks", "before", "visit", "1" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02140255
26:29:chronic_disease,
Two consecutive negative HIV antibody tests by fourth generation enzyme-linked immunosorbent assay (ELISA) (performed in the study's designated central laboratory) at least 8 weeks apart
1
[ "Two", "consecutive", "negative", "HIV", "antibody", "tests", "by", "fourth", "generation", "enzyme-linked", "immunosorbent", "assay", "(", "ELISA", ")", "(", "performed", "in", "the", "study", "'s", "designated", "central", "laboratory", ")", "at", "least", "8", "weeks", "apart" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02953509
1:4:chronic_disease
HIV
1
[ "HIV" ]
[ 2 ]
NCT02822599
53:71:treatment
Neonatal and infant cardiac patients presenting for open-heart surgery at Nicklaus Children's Hospital
1
[ "Neonatal", "and", "infant", "cardiac", "patients", "presenting", "for", "open-heart", "surgery", "at", "Nicklaus", "Children", "'s", "Hospital" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02657993
1:30:treatment,
Non-steroidal joint injection within the last 3 months
1
[ "Non-steroidal", "joint", "injection", "within", "the", "last", "3", "months" ]
[ 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02519322
1:25:cancer,
oligometastatic melanoma is defined as three or fewer areas of resectable disease excluding central nervous system and bone involvement
1
[ "oligometastatic", "melanoma", "is", "defined", "as", "three", "or", "fewer", "areas", "of", "resectable", "disease", "excluding", "central", "nervous", "system", "and", "bone", "involvement" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01760655
1:23:cancer
Acute myeloid leukemia with high risk features
1
[ "Acute", "myeloid", "leukemia", "with", "high", "risk", "features" ]
[ 3, 3, 3, 0, 0, 0, 0 ]
NCT02400463
7:10:chronic_disease
known HIV infection
1
[ "known", "HIV", "infection" ]
[ 0, 2, 0 ]
NCT02268253
42:59:chronic_disease,67:104:chronic_disease,106:128:chronic_disease
has uncontrolled, clinically significant pulmonary disease (e.g., chronic obstructive pulmonary disease, pulmonary hypertension) that, in the Investigator's opinion, would put the patient at significant risk for pulmonary complications during the study
1
[ "has", "uncontrolled", ",", "clinically", "significant", "pulmonary", "disease", "(", "e.g.", ",", "chronic", "obstructive", "pulmonary", "disease", ",", "pulmonary", "hypertension", ")", "that", ",", "in", "the", "Investigator", "'s", "opinion", ",", "would", "put", "the", "patient", "at", "significant", "risk", "for", "pulmonary", "complications", "during", "the", "study" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02237183
46:54:treatment
Participants must not have been treated with iloprost at any time
1
[ "Participants", "must", "not", "have", "been", "treated", "with", "iloprost", "at", "any", "time" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT00483249
58:89:treatment
Anticipated mortality comparable to published rates with conventional surgical treatment
1
[ "Anticipated", "mortality", "comparable", "to", "published", "rates", "with", "conventional", "surgical", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02400463
25:41:cancer
tissue demonstration of hemophagocytosis
1
[ "tissue", "demonstration", "of", "hemophagocytosis" ]
[ 0, 0, 0, 3 ]
NCT02367040
1:18:chronic_disease,14:17:chronic_disease,22:39:chronic_disease,35:38:chronic_disease,159:189:treatment
Hepatitis B (HBV) or hepatitis C (HCV). Patients positive for HBsAg or HBcAb will be eligible if they are negative for HBV-DNA, these patients should receive prophylactic antiviral therapy. Patients positive for anti- HCV antibody will be eligible if they are negative for HCV-RNA
1
[ "Hepatitis", "B", "(", "HBV", ")", "or", "hepatitis", "C", "(", "HCV", ")", ".", "Patients", "positive", "for", "HBsAg", "or", "HBcAb", "will", "be", "eligible", "if", "they", "are", "negative", "for", "HBV-DNA", ",", "these", "patients", "should", "receive", "prophylactic", "antiviral", "therapy", ".", "Patients", "positive", "for", "anti-", "HCV", "antibody", "will", "be", "eligible", "if", "they", "are", "negative", "for", "HCV-RNA" ]
[ 2, 2, 2, 2, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03181126
,73:85:treatment
Refractory is defined as persistent disease after at least 2 courses of chemotherapy
1
[ "Refractory", "is", "defined", "as", "persistent", "disease", "after", "at", "least", "2", "courses", "of", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02271919
15:24:treatment
Interested in treatment that might change smoking behavior
1
[ "Interested", "in", "treatment", "that", "might", "change", "smoking", "behavior" ]
[ 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT03011684
5:18:cancer
New breast cancer diagnosis
1
[ "New", "breast", "cancer", "diagnosis" ]
[ 0, 3, 3, 0 ]
NCT03043794
1:15:treatment
Breast implant in the involved breast
1
[ "Breast", "implant", "in", "the", "involved", "breast" ]
[ 1, 1, 0, 0, 0, 0 ]
NCT02857218
40:51:allergy_name
a known history of hypersensitivity to ferumoxytol
1
[ "a", "known", "history", "of", "hypersensitivity", "to", "ferumoxytol" ]
[ 0, 0, 0, 0, 0, 0, 4 ]
NCT03138733
1:54:chronic_disease,130:142:treatment,146:155:treatment
Bloodstream or non-bloodstream concomitant infections with Gram-negative bacteria that are known to be non-susceptible to either ceftobiprole or aztreonam
1
[ "Bloodstream", "or", "non-bloodstream", "concomitant", "infections", "with", "Gram-negative", "bacteria", "that", "are", "known", "to", "be", "non-susceptible", "to", "either", "ceftobiprole", "or", "aztreonam" ]
[ 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
NCT02898597
12:36:chronic_disease,44:57:chronic_disease,62:78:chronic_disease
History of serious mental illnesses (e.g., schizophrenia and bipolar disorder)
1
[ "History", "of", "serious", "mental", "illnesses", "(", "e.g.", ",", "schizophrenia", "and", "bipolar", "disorder", ")" ]
[ 0, 0, 2, 2, 2, 0, 0, 0, 2, 0, 2, 2, 0 ]
NCT02209636
8:17:treatment,37:47:treatment,49:61:treatment,63:78:treatment
Active vitamin D analogue use (i.e. calcitriol, paricalcitol, doxercalciferol)
1
[ "Active", "vitamin", "D", "analogue", "use", "(", "i.e", ".", "calcitriol", ",", "paricalcitol", ",", "doxercalciferol", ")" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0 ]
NCT02172651
102:111:allergy_name
History of allergic reactions attributed to compounds of similar chemical or biologic composition to vitamin D
1
[ "History", "of", "allergic", "reactions", "attributed", "to", "compounds", "of", "similar", "chemical", "or", "biologic", "composition", "to", "vitamin", "D" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4 ]
NCT02287337
26:35:treatment
Inability to comply with treatment and follow-up schedule
1
[ "Inability", "to", "comply", "with", "treatment", "and", "follow-up", "schedule" ]
[ 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02273375
34:45:chronic_disease
Patients with a past or resolved hepatitis B infection (defined as presence of hepatitis B core antibody (anti-HBc) and absence of HBSAg) are eligible
1
[ "Patients", "with", "a", "past", "or", "resolved", "hepatitis", "B", "infection", "(", "defined", "as", "presence", "of", "hepatitis", "B", "core", "antibody", "(", "anti-HBc", ")", "and", "absence", "of", "HBSAg", ")", "are", "eligible" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02836574
54:67:treatment
anatomic abnormalities that would interfere with the NKA injection procedure
1
[ "anatomic", "abnormalities", "that", "would", "interfere", "with", "the", "NKA", "injection", "procedure" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0 ]
NCT02988960
48:88:cancer
Participant must not have a known uncontrolled malignancy of the central nervous system
1
[ "Participant", "must", "not", "have", "a", "known", "uncontrolled", "malignancy", "of", "the", "central", "nervous", "system" ]
[ 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 3, 3 ]
NCT01409161
16:19:cancer,49:90:treatment,92:123:treatment,128:136:treatment
A diagnosis of APL based on the presence of the PML-RAR-alpha fusion gene by cytogenetics, polymerase chain reaction (PCR), or POD test
1
[ "A", "diagnosis", "of", "APL", "based", "on", "the", "presence", "of", "the", "PML-RAR-alpha", "fusion", "gene", "by", "cytogenetics", ",", "polymerase", "chain", "reaction", "(", "PCR", ")", ",", "or", "POD", "test" ]
[ 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 1 ]
NCT02522715
,,61:70:allergy_name,72:86:allergy_name,141:153:allergy_name,165:173:allergy_name,175:199:allergy_name,205:229:allergy_name
History of severe hypersensitivity reaction (>= grade 3) to docetaxel, polysorbate 80 containing drugs, or any of the capsule components of enzalutamide, including Labrasol, butylated hydroxyanisole, and butylated hydroxytoluene
1
[ "History", "of", "severe", "hypersensitivity", "reaction", "(", ">", "=", "grade", "3", ")", "to", "docetaxel", ",", "polysorbate", "80", "containing", "drugs", ",", "or", "any", "of", "the", "capsule", "components", "of", "enzalutamide", ",", "including", "Labrasol", ",", "butylated", "hydroxyanisole", ",", "and", "butylated", "hydroxytoluene" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 4, 0, 4, 4, 0, 0, 0, 0 ]
NCT02496611
12:24:chronic_disease
History of pancreatitis
1
[ "History", "of", "pancreatitis" ]
[ 0, 0, 2 ]
NCT02876302
26:28:cancer,30:32:cancer,38:42:cancer,61:97:cancer
Patients must have known ER, PR, and HER2 status defined as triple-negative breast cancer (TNBC)
1
[ "Patients", "must", "have", "known", "ER", ",", "PR", ",", "and", "HER2", "status", "defined", "as", "triple-negative", "breast", "cancer", "(", "TNBC", ")" ]
[ 0, 0, 0, 0, 3, 0, 3, 0, 0, 3, 0, 0, 0, 3, 3, 3, 3, 0, 0 ]
NCT03017118
1:30:chronic_disease
Post-traumatic osteoarthritis
1
[ "Post-traumatic", "osteoarthritis" ]
[ 2, 2 ]
NCT02842658
1:16:chronic_disease
Unstable angina
1
[ "Unstable", "angina" ]
[ 2, 2 ]
NCT02624258
21:32:chronic_disease,
Patients with prior CNS disease that has been effectively treated will be eligible providing treatment was >4 weeks before enrollment
1
[ "Patients", "with", "prior", "CNS", "disease", "that", "has", "been", "effectively", "treated", "will", "be", "eligible", "providing", "treatment", "was", ">", "4", "weeks", "before", "enrollment" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02013154
1:6:cancer
Tumor tissue for mandatory evaluation
1
[ "Tumor", "tissue", "for", "mandatory", "evaluation" ]
[ 3, 0, 0, 0, 0 ]
NCT02669966
34:37:chronic_disease
The donor candidate must be anti-HCV positive by ELISA and HCV RNA negative by PCR, with both tests repeated for confirmation, as per standard protocol
1
[ "The", "donor", "candidate", "must", "be", "anti-HCV", "positive", "by", "ELISA", "and", "HCV", "RNA", "negative", "by", "PCR", ",", "with", "both", "tests", "repeated", "for", "confirmation", ",", "as", "per", "standard", "protocol" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02493530
18:52:chronic_disease
Known history of human immunodeficiency virus (HIV)
1
[ "Known", "history", "of", "human", "immunodeficiency", "virus", "(", "HIV", ")" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02013778
24:48:cancer,134:137:cancer,141:147:treatment,,300:303:treatment,307:309:treatment,,400:409:chronic_disease,417:436:chronic_disease,,
Patient diagnosed with hepatocellular carcinoma in both lobes of the liver by one of the following methods (Pathologically confirmed HCC by biopsy or HCC 2 cm with classic radiographic findings of arterial phase enhancement with venous phase washout and pseudocapsule formation on contrast enhanced MRI or CT or Lesion greater than 2 cm with probable imaging features of HCC and imaging findings of cirrhosis and/or portal hypertension or a serum alphafetoprotein (AFP) greater than 200 mg/mL
1
[ "Patient", "diagnosed", "with", "hepatocellular", "carcinoma", "in", "both", "lobes", "of", "the", "liver", "by", "one", "of", "the", "following", "methods", "(", "Pathologically", "confirmed", "HCC", "by", "biopsy", "or", "HCC", "2", "cm", "with", "classic", "radiographic", "findings", "of", "arterial", "phase", "enhancement", "with", "venous", "phase", "washout", "and", "pseudocapsule", "formation", "on", "contrast", "enhanced", "MRI", "or", "CT", "or", "Lesion", "greater", "than", "2", "cm", "with", "probable", "imaging", "features", "of", "HCC", "and", "imaging", "findings", "of", "cirrhosis", "and/or", "portal", "hypertension", "or", "a", "serum", "alphafetoprotein", "(", "AFP", ")", "greater", "than", "200", "mg/mL" ]
[ 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02290951
52:64:allergy_name
History of hypersensitivity to any compound in the tetracycline antibiotics group
1
[ "History", "of", "hypersensitivity", "to", "any", "compound", "in", "the", "tetracycline", "antibiotics", "group" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0 ]
NCT02635360
1:13:treatment
chemotherapy
1
[ "chemotherapy" ]
[ 1 ]
NCT02764853
1:4:chronic_disease
HIV-positive
1
[ "HIV-positive" ]
[ 2 ]
NCT03153410
33:45:treatment,
Must have received last dose of chemotherapy at least 14 days or longer prior to entry into the study
1
[ "Must", "have", "received", "last", "dose", "of", "chemotherapy", "at", "least", "14", "days", "or", "longer", "prior", "to", "entry", "into", "the", "study" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02660528
1:37:chronic_disease,,,
Abnormal thyroid-stimulating hormone (TSH <0.4 or >5.0mlU/L)
1
[ "Abnormal", "thyroid-stimulating", "hormone", "(", "TSH", "<", "0.4", "or", ">", "5.0mlU/L", ")" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02140255
15:19:treatment,
No receipt of ARVs during the current pregnancy
1
[ "No", "receipt", "of", "ARVs", "during", "the", "current", "pregnancy" ]
[ 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT02656706
15:30:chronic_disease,61:77:chronic_disease,,114:135:chronic_disease,
Patients with unstable angina (anginal symptoms at rest) or new-onset angina (began within the last 3 months) or myocardial infarction within the past 6 months
1
[ "Patients", "with", "unstable", "angina", "(", "anginal", "symptoms", "at", "rest", ")", "or", "new-onset", "angina", "(", "began", "within", "the", "last", "3", "months", ")", "or", "myocardial", "infarction", "within", "the", "past", "6", "months" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT02503358
33:42:treatment
Patients who progressed on such treatment, i.e., have developed acquired resistance and are no longer reasonably expected to derive therapeutic benefit are eligible for the trial
1
[ "Patients", "who", "progressed", "on", "such", "treatment", ",", "i.e.", ",", "have", "developed", "acquired", "resistance", "and", "are", "no", "longer", "reasonably", "expected", "to", "derive", "therapeutic", "benefit", "are", "eligible", "for", "the", "trial" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02843945
1:13:treatment,,
Chemotherapy was administered for 2-6 cycles with any combination
1
[ "Chemotherapy", "was", "administered", "for", "2-6", "cycles", "with", "any", "combination" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01989585
14:34:chronic_disease,77:101:chronic_disease,115:139:chronic_disease,141:165:chronic_disease,167:185:chronic_disease,187:208:chronic_disease,213:232:chronic_disease,233:250:chronic_disease
Uncontrolled intercurrent illness including, but not limited to, ongoing or active serious infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, uncontrolled diabetes, or psychiatric illness/social situations that would limit compliance with study requirements
1
[ "Uncontrolled", "intercurrent", "illness", "including", ",", "but", "not", "limited", "to", ",", "ongoing", "or", "active", "serious", "infection", ",", "symptomatic", "congestive", "heart", "failure", ",", "unstable", "angina", "pectoris", ",", "cardiac", "arrhythmia", ",", "uncontrolled", "diabetes", ",", "or", "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT00720785
1:4:chronic_disease
HIV-positive patients
1
[ "HIV-positive", "patients" ]
[ 2, 0 ]
NCT02342808
1:11:chronic_disease,,
Severe CKD (eGFR <40 ml/min/1.73m2)
1
[ "Severe", "CKD", "(", "eGFR", "<", "40", "ml/min/1.73m2", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02140255
11:14:chronic_disease
No plasma HIV RNA detected at the time of the second consecutive negative HIV DNA test (based on testing performed in the study's designated VQA-certified central laboratory)
1
[ "No", "plasma", "HIV", "RNA", "detected", "at", "the", "time", "of", "the", "second", "consecutive", "negative", "HIV", "DNA", "test", "(", "based", "on", "testing", "performed", "in", "the", "study", "'s", "designated", "VQA-certified", "central", "laboratory", ")" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00351611
,,25:44:treatment
Currently taking 1 to 3 antiepileptic drugs
1
[ "Currently", "taking", "1", "to", "3", "antiepileptic", "drugs" ]
[ 0, 0, 0, 0, 0, 1, 1 ]
NCT02335138
30:33:chronic_disease,
Willingness to be tested for HIV with one's male sexual partner
1
[ "Willingness", "to", "be", "tested", "for", "HIV", "with", "one", "'s", "male", "sexual", "partner" ]
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0 ]
NCT02541903
15:37:chronic_disease
Any active or uncontrolled infection
1
[ "Any", "active", "or", "uncontrolled", "infection" ]
[ 0, 0, 0, 2, 2 ]